Fiera Capital (Europe)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$237K Hold
4,347
0.11% 33
2016
Q4
$253K Hold
4,347
0.15% 28
2016
Q3
$235K Hold
4,347
0.14% 34
2016
Q2
$319K Sell
4,347
-572
-12% -$40.4K 0.25% 24
2016
Q1
$315K Buy
4,919
+1,887
+62% +$119K 0.31% 22
2015
Q4
$209K Hold
3,032
0.25% 33
2015
Q3
$180K Hold
3,032
0.24% 33
2015
Q2
$202K Sell
3,032
-678
-18% -$44.7K 0.18% 33
2015
Q1
$240K Buy
3,710
+1,954
+111% +$122K 0.22% 31
2014
Q4
$197K Sell
1,756
-2,671
-60% -$151K 0.14% 34
2014
Q3
$227K Hold
4,427
0.16% 31
2014
Q2
$214K Buy
4,427
+605
+16% +$29.8K 0.17% 27
2014
Q1
$198K Buy
3,822
+1,122
+42% +$59.7K 0.15% 26
2013
Q4
$143K Buy
+2,700
New +$138K 0.08% 29

Other funds holding BMY

Fiera Capital (Europe)'s BMY Position: Q1 2017 in Review

Fiera Capital (Europe) held its Bristol-Myers Squibb (BMY) position steady in Q1 2017 at 4,347 shares worth $237K. The position accounts for 0.11% of the portfolio, ranked #33.

Fiera Capital (Europe) first reported a position in BMY in Q4 2013 and has held it in 14 quarters since. The position peaked at $319K in Q2 2016. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • Fiera Capital (Europe) held 4,347 shares of Bristol-Myers Squibb worth $237K as of Q1 2017.
  • Fiera Capital (Europe) left its Bristol-Myers Squibb share count unchanged in Q1 2017.
  • Bristol-Myers Squibb made up 0.11% of Fiera Capital (Europe)'s portfolio in Q1 2017, its #33 holding.
  • Fiera Capital (Europe) first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 14 quarters since.
  • Fiera Capital (Europe)'s Bristol-Myers Squibb position peaked at $319K in Q2 2016.
  • 1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Fiera Capital (Europe)'s 13F filing for Q1 2017, filed 15 May 2017.